Genome-wide characteristics of de novo mutations in autism

npj Genomic Medicine

Volumn 1, Issue , 2016, Pages

  Yuen, Ryan K C ^a   Merico, Daniele ^a,b   Cao, Hongzhi ^c   Pellecchia, Giovanna ^a   Alipanahi, Babak ^b,d   Thiruvahindrapuram, Bhooma ^a   Tong, Xin ^c   Sun, Yuhui ^c   Cao, Dandan ^c   Zhang, Tao ^c   Wu, Xueli ^c   Jin, Xin ^c   Zhou, Ze ^c   Liu, Xiaomin ^c   Nalpathamkalam, Thomas ^a   Walker, Susan ^a   Howe, Jennifer L ^a   Wang, Zhuozhi ^a   Macdonald, Jeffrey R ^a   Chan, Ada J S ^a,e   D'Abate, Lia ^a,e   Deneault, Eric ^a   Siu, Michelle T ^f   Tammimies, Kristiina ^g   Uddin, Mohammed ^a   Zarrei, Mehdi ^a   Wang, Mingbang ^c   Li, Yingrui ^c   Wang, Jun ^c   Wang, Jian ^c   Yang, Huanming ^c   Bookman, Matt ^h,i   Bingham, Jonathan ^h,i   Gross, Samuel S ^h,i   Loy, Dion ^h,i   Pletcher, Mathew ^j   Marshall, Christian R ^a,f   Anagnostou, Evdokia ^k   Zwaigenbaum, Lonnie ^l   Weksberg, Rosanna ^d,e,f   Fernandez, Bridget A ^m,n   Roberts, Wendy ^f   Szatmari, Peter ^d,f,o   Glazer, David ^h,i   Frey, Brendan J ^b,d,e   Ring, Robert H ^j   Xu, Xun ^c   Scherer, Stephen W ^a,d,e   more..

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Deep Genomics Inc   (Canada)

^c BGI SHENZHEN   (China)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g KAROLINSKA INSTITUTE   (Sweden)

^h GOOGLE INC   (United States)

ⁱ VERILY LIFE SCIENCES   (United States)

^j Autism Speaks Inc   (United States)

^k University of Toronto   (Canada)

^l UNIVERSITY OF ALBERTA   (Canada)

^m MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

ⁿ Eastern Health Canada   (Canada)

^o CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85028621089     PISSN: None     EISSN: 20567944     Source Type: Journal    
DOI: 10.1038/npjgenmed.2016.27     Document Type: Article

References (70)

1. Anagnostou, E. et al. Autism spectrum disorder: Advances in evidence-based practice. CMAJ. 186, 509-519 (2014).
2. Colvert, E. et al. Heritability of autism spectrum disorder in a UK population-based twin sample. JAMA Psychiatry 72, 415-423 (2015).
3. Ozonoff, S. et al. Recurrence risk for autism spectrum disorders: A Baby Siblings Research Consortium study. Pediatrics 128, e488-e495 (2011).
4. Fombonne, E. Epidemiology of pervasive developmental disorders. Pediatr. Res. 65, 591-598 (2009).
5. Pinto, D. et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am. J. Hum. Genet. 94, 677-694 (2014).
6. Sanders, S. J. et al. Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron 87, 1215-1233 (2015).
7. Jiang, Y. H. et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am. J. Hum. Genet. 93, 249-263 (2013).
8. Dong, S. et al. De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. Cell Rep. 9, 16-23 (2014).
9. De Rubeis, S. et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209-215 (2014).
10. Buxbaum, J. D. et al. The autism sequencing consortium: large-scale, highthroughput sequencing in autism spectrum disorders. Neuron 76, 1052-1056 (2012).
11. Carter, M. T. & Scherer, S. W. Autism spectrum disorder in the genetics clinic: A review. Clin. Genet. 83, 399-407 (2013).
12. Tammimies, K. et al. Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder. JAMA 314, 895-903 (2015).
13. Anney, R. et al. Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum. Mol. Genet. 21, 4781-4792 (2012).
14. Sebat, J. et al. Strong association of de novo copy number mutations with autism. Science 316, 445-449 (2007).
15. Ronemus, M., Iossifov, I., Levy, D. & Wigler, M. The role of de novo mutations in the genetics of autism spectrum disorders. Nat. Rev. Genet. 15, 133-141 (2014).
16. Uddin, M. et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat. Genet. 46, 742-747 (2014).
17. Autism Genome Project C. et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39, 319-328 (2007).
18. Yuen, R. K. et al. Whole-genome sequencing of quartet families with autism spectrum disorder. Nat. Med. 21, 185-191 (2015).
19. Awadalla, P. et al. Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am. J. Hum. Genet. 87, 316-324 (2010).
20. Kong, A. et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488, 471-475 (2012).
21. Francioli, L. C. et al. Genome-wide patterns and properties of de novo mutations in humans. Nat. Genet. 47, 822-826 (2015).
22. Carvalho, C. M. et al. Replicative mechanisms for CNV formation are error prone. Nat. Genet. 45, 1319-1326 (2013).
23. Baarends, W. M., van der Laan, R. & Grootegoed, J. A. DNA repair mechanisms and gametogenesis. Reproduction 121, 31-39 (2001).
24. Pang, A. W., Macdonald, J. R., Yuen, R. K., Hayes, V. M. & Scherer, S. W. Performance of high-Throughput sequencing for the discovery of genetic variation across the complete size spectrum. G3 (Bethesda) 4, 63-65 (2014).
25. Kim, H. G. et al. Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet. 82, 199-207 (2008).
26. Genome of the Netherlands C. Whole-genome sequence variation, population structure and demographic history of the Dutch population. Nat. Genet. 46, 818-825 (2014).
27. Iossifov, I. et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515, 216-221 (2014).
28. Xiong, H. Y. et al. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease. Science 347, 1254806 (2015).
29. Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
30. Roadmap Epigenomics, C. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330 (2015).
31. Choufani, S. et al. NSD1 mutations generate a genome-wide DNA methylation signature. Nat. Commun. 6, 10207 (2015).
32. Harper, K. N., Peters, B. A. & Gamble, M. V. Batch effects and pathway analysis: Two potential perils in cancer studies involving DNA methylation array analysis. Cancer Epidemiol. Biomarkers Prev. 22, 1052-1060 (2013).
33. Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257 (1999).
34. Tatton-Brown, K. et al. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat. Genet. 46, 385-388 (2014).
35. Mandel, S. & Gozes, I. Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex. J. Biol. Chem. 282, 34448-34456 (2007).
36. Helsmoortel, C. et al. A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Nat. Genet. 46, 380-384 (2014).
37. Schotta, G. et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 18, 1251-1262 (2004).
38. Noor, A. et al. Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. Sci. Transl. Med. 2, 49ra68 (2010).
39. Marshall, C. R. et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82, 477-488 (2008).
40. Hodge, J. C. et al. Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities. Mol. Psychiatry 19, 368-379 (2014).
41. Duong, L. T. et al. Two rare deletions upstream of the NRXN1 gene (2p16.3) affecting the non-coding mRNA AK127244 segregate with diverse psychopathological phenotypes in a family. Eur. J. Med. Genet. 58, 650-653 (2015).
42. Talkowski, M. E. et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 149, 525-537 (2012).
43. Campbell, I. M. et al. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am. J. Hum. Genet. 95, 173-182 (2014).
44. D'Gama, A. M. et al. Targeted DNA sequencing from autism spectrum disorder brains implicates multiple genetic mechanisms. Neuron 88, 910-917 (2015).
45. Stavropoulos, D. J. et al. Whole genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine. NPJ Genom. Med. 1, 15012 (2016).
46. Zheng, G. X. et al. Haplotyping germline and cancer genomes with highthroughput linked-read sequencing. Nat. Biotechnol. 34, 303-311 (2016).
47. English, A. C. et al. Assessing structural variation in a personal genome-Towards a human reference diploid genome. BMC Genomics 16, 286 (2015).
48. Noll, A. C. et al. Clinical detection of deletion structural variants in whole genome sequences. NPJ Genom. Med. 1, 16026 (2016).
49. Bailey, A., Phillips, W. & Rutter, M. Autism: Towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives. J. Child Psychol. Psychiatry 37, 89-126 (1996).
50. Bourgeron, T. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat. Rev. Neurosci. 16, 551-563 (2015).
51. Devlin, B. & Scherer, S. W. Genetic architecture in autism spectrum disorder. Curr. Opin. Genet. Dev. 22, 229-237 (2012).
52. He, X. et al. Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes. PLoS Genet. 9, e1003671 (2013).
53. Chiang, D. Y. et al. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat. Methods 6, 99-103 (2009).
54. Zhu, M. et al. Using ERDS to infer copy-number variants in high-coverage genomes. Am. J. Hum. Genet. 91, 408-421 (2012).
55. Yang, L. et al. Diverse mechanisms of somatic structural variations in human cancer genomes. Cell 153, 919-929 (2013).
56. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-Throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
57. Pollard, K. S., Hubisz, M. J., Rosenbloom, K. R. & Siepel, A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 20, 110-121 (2010).
58. Ng, P. C. & Henikoff, S. Predicting deleterious amino acid substitutions. Genome Res. 11, 863-874 (2001).
59. Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248-249 (2010).
60. Reva, B., Antipin, Y. & Sander, C. Predicting the functional impact of protein mutations: Application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).
61. Schwarz, J. M., Rodelsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7, 575-576 (2010).
62. Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310-315 (2014).
63. Andersson, R. et al. An atlas of active enhancers across human cell types and tissues. Nature 507, 455-461 (2014).
64. Visel, A. et al. A high-resolution enhancer atlas of the developing telencephalon. Cell 152, 895-908 (2013).
65. Alipanahi, B., Delong, A., Weirauch, M. T. & Frey, B. J. Predicting the sequence specificities of DNA-And RNA-binding proteins by deep learning. Nat. Biotechnol. 33, 831-838 (2015).
66. Khurana, E. et al. Integrative annotation of variants from 1092 humans: Application to cancer genomics. Science 342, 1235587 (2013).
67. Merico, D., Isserlin, R., Stueker, O., Emili, A. & Bader, G. D. Enrichment map: A network-based method for gene set enrichment visualization and interpretation. PLoS ONE 5, e13984 (2010).
68. Triche, T. J. Jr, Weisenberger, D. J., Van Den Berg, D., Laird, P. W. & Siegmund, K. D. Low-level processing of Illumina Infinium DNA Methylation BeadArrays. Nucleic Acids Res. 41, e90 (2013).
69. Maksimovic, J., Gordon, L. & Oshlack, A. SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol. 13, R44 (2012).
70. Houseman, E. A. et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13, 86 (2012).